Bharat Biotech's intranasal Covid vaccine priced at Rs 800
Bharat biotech News Collection
-
-
Centre approves Bharat Biotech's intranasal Covid vaccine for booster
-
DCGI nod to Bharat Biotech's Intranasal Covid booster dose for restricted use
-
Health Ministry rejects claim 'Covaxin was rushed due to political pressure'
-
Bharat Biotech completes trials for intranasal Covid vax - BBV154
-
-
Bharat Biotech's intranasal Covid vaccine proven safe in clinical trials
-
Covaxin safe for children aged 2-18 years, says Bharat Biotech
-
Germany approves Bharat Biotech's Covaxin
-
Ocugen to commercialise Covaxin in Mexico
-
-
Bharat Biotech toes Serum line, to provide Covaxin at Rs 225; booster dose from today
-
Bharat Biotech donates Rs. 1 crore for Vijayawada’s Kanaka Durga temple, highest till date
-
Bharat Biotech announces slowing down of Covaxin production
-
Bharat Biotech partners with Biofabri to develop TB vaccine
-
DCGI permits Bharat Biotech to conduct trials for intranasal booster dose
-
Couple behind India's indigenous Covid vaccine gets Padma Bhushan
-
Covaxin booster can neutralise Omicron: Bharat Biotech
-
Covaxin booster dose trial shows 'long-term safety': Bharat Biotech
-
Paracetamol not recommended after getting Covaxin jab: Bharat Biotech
-
DGCI approves for phase III trial of Bharat Biotech intranasal vaccine as booster
-
Covaxin for children proven to be safe in paediatric subjects in study: Bharat Biotech
-
Bharat Biotech targets one billion doses of intranasal vaccine annually
-
Bharat Biotech seeks approval for Phase 3 trials of intranasal vaccine
-
Opened Covaxin vial can be stored for 28 days, says Bharat Biotech
-
Bharat Biotech begins export of Covaxin
-
Results provide evidence for effectiveness: Bharat Biotech on Covaxin study
-
Developing Covaxin was an enormous challenge: Bharat Biotech
-
Six months after second dose ideal time for booster: Bharat Biotech CMD
-
UK to add India's Covaxin to approved list from Nov 22
-
Bharat Biotech's US partner Ocugen seeks Covaxin approval for kids
-
WHO approves Covaxin, Health Minister hails ICMR, Bharat Biotech scientists
-
Vax for children: Bharat Biotech awaits further regulatory approval
-
Diligently working with WHO to obtain EUL for Covaxin: Bharat Biotech
-
Vaccine must not be entry barrier for nations: Bharat Biotech Co-Founder
-
Mandaviya releases 1st commercial batch of Covaxin from Bharat Biotech's new plant
-
Bharat Biotech recalls combopack due to printing error